1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Who's replacing Marvin??

Discussion in 'Kimberly-Clark' started by Anonymous, May 2, 2014 at 6:26 PM.

  1. Anonymous

    Anonymous Guest

    Anyone heard anything
     
  2. Anonymous

    Anonymous Guest

    Who is "Starving" Marvin. Maybe David Parks will come back to continue the incompetence!!!
     
  3. Anonymous

    Anonymous Guest

    I just heard Marvin spears us no longer pain director of sales. Who's stepping into his role?
     
  4. Anonymous

    Anonymous Guest

    Hum women women
     
  5. Anonymous

    Anonymous Guest

    As Hillary Clinton said "what does it really matter". Replace a loser with another loser and I can assure you it will be a woman!!!
     
  6. Anonymous

    Anonymous Guest

    Don't know. Hope it's someone who can lead us and help. I don't think any of the current managers are ready to step into that role.